Strategies for improving treatment of bipolar disorder: Integration of measurement and management

Acta Psychiatrica Scandinavica, Supplement

Volumn 110, Issue 422 SUPPL., 2004, Pages 7-17

  Sachs, Gary S ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Assessment; Bipolar disorder; Clinical management; Clinical outcomes; Treatment

Indexed keywords

ARIPIPRAZOLE; CARBAMAZEPINE; CLOZAPINE; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; OLANZAPINE; OMEGA 3 FATTY ACID; OXCARBAZEPINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROATE SEMISODIUM; ZIPRASIDONE;

BIPOLAR DISORDER; CLINICAL FEATURE; CLINICAL PRACTICE; DISABILITY; DISEASE COURSE; DRUG RESPONSE; EVIDENCE BASED MEDICINE; FAMILY HISTORY; HEALTH CARE COST; INTERPERSONAL COMMUNICATION; MEASUREMENT; MEDICAL DECISION MAKING; ONSET AGE; PATIENT EDUCATION; PRACTICE GUIDELINE; REVIEW; SCORING SYSTEM; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; EDUCATION; ELECTROENCEPHALOGRAM; HEALTH PROGRAM; HUMAN; LABORATORY TEST; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RATING SCALE; STANDARD; TREATMENT OUTCOME; TREATMENT PLANNING; ARTICLE; CHRONIC DISEASE; HOSPITALIZATION; MENTAL HEALTH SERVICE; ORGANIZATION AND MANAGEMENT; UNITED STATES;

BIPOLAR DISORDER; CHRONIC DISEASE; HUMANS; MENTAL HEALTH SERVICES; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 4644285054     PISSN: 00651591     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2004.00409.x     Document Type: Review

References (23)

1. LOPEZ AD, MURRAY CC. The global burden of disease, 1990-2020. Nat Med 1998;4:1241-1243.
2. DE ZELICOURT M. et al. Frequency of hospitalisations and inpatient care costs of manic episodes: in patients with bipolar I disorder in France. Pharmacoeconomics 2003;21:1081-1090.
3. PEELE PB, XU Y, KUPFER DJ. Insurance expenditures on bipolar disorder: clinical and parity implications. Am J Psychiatry 2003;160:1286-1290.
4. DEAN BB, GERNER D, GERNER RH. A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder. Curr Med Res Opin 2004;20:139-154.
5. ANGST J. et al. Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord 2003;73:133-146.
6. LISH JD. et al. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord 1994;31:281-294.
7. GHAEMI SN. et al. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affect Disord 1999;52:135-144.
8. HIRSCHFELD RM, LEWIS L, VORNIK LA. Perceptions and impact of bipolar disorder, how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry 2003;64:161-174.
9. CASAT CD. The under- and over-diagnosis of mania in Children and adolescents. Compr Psychiatry 1982;23:552-559.
10. POGGE DL. et al. Diagnosis of manic episodes in adolescent inpatients: structured diagnostic procedures compared to clinical chart diagnoses. Psychiatry Res 2001;101:47-54.
11. PARIS J. Re: Misdiagnosis of bipolar affective disorder as personality disorder. Can J Psychiatry 1994;39:315.
12. ANGST F. et al. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002;68:167-181.
13. BAUER MS. et al. Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs. J Clin Psychiatry 1999;60:9-21.
14. SACHS GS. et al. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med 2000: Spec No: 1-104.
15. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002;159 (4 Suppl.): 1-50.
16. SUPPES T. et al. Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000. J Clin Psychiatry 2002;63:288-299.
17. SACHS G. Managing Bipolar Affective Disorder 2004. London: Science Press Ltd.
18. FIRST MB. et al. Structured clinical interview for DSM-IV axis I disorders-clinician version (SCID-CV) 1997: Washington (DC). American Psychiatric Press.
19. KRAEPELIN E. Manic-Depressive Insanity and Paranoia 1921. Edinburgh: E & S Livingstone.
20. LEONHARD K. Uber monopolare und bipolare endogene Psychosen. Nervenarzt 1968;39:104-106.
21. ANGST J, MARNEROS A. Bipolarity from ancient to modern times: conception, birth and rebirth. J Affect Disord 2001;67:3-19.
22. FAVA GA. Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications. Psychol Med 1999;29:47-61.
23. KELLER MB. et al. Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium. Arch General Psychiatry 1992;49:371-376.